News
![If I Could Buy Only 1 Stock, This Would Be It](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
If I Could Buy Only 1 Stock, This Would Be It
What are the top three things you like in a stock? For me, the answer is pretty easy: I like growth most of all. Everyone wants their stocks to appreciate in value.Second, I like dividends. The....
![The Clear Reason Why Stemline Therapeutics Inc. Skyrocketed as Much as 33%](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
The Clear Reason Why Stemline Therapeutics Inc. Skyrocketed as Much as 33%
Shares of Stemline Therapeutics (NASDAQ: STML), a small-cap clinical-stage biotechnology company with a focus on developing medicines to treat cancer, skyrocketed as much as 33% during Tuesday's....
![Ionis Down Big on Analyst Miss](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Ionis Down Big on Analyst Miss
This week, Biogen (NASDAQ: BIIB) reported earnings, and Ionis Pharmaceuticals' (NASDAQ: IONS) stock sold off significantly on the news that its drug Spinraza, which Biogen helps commercialize,....
![Why Endo International plc Jumped and Then Faded -- Twice](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Why Endo International plc Jumped and Then Faded -- Twice
Endo International (NASDAQ: ENDP) was up as much as 13.6% Tuesday before settling down to about half that gain after reporting preliminary third-quarter revenue and earnings results on Monday. The....
![Why Novavax Stock Is Soaring Today](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Why Novavax Stock Is Soaring Today
Shares of flu vaccine researcher Novavax (NASDAQ: NVAX) shot up 13.7% in early trading Tuesday after a positive analyst note out of Citigroup predicted "strong market opportunities" for the....
![Why Exact Sciences Shares Are Soaring 11.6% Today](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Why Exact Sciences Shares Are Soaring 11.6% Today
After the company reported better-than-expected top- and bottom-line third-quarter results today, shares of Exact Sciences (NASDAQ: EXAS) are jumping 11.6% at 12:30 p.m. EDT.As many as 20 million....
![Novavax Stock Upgraded: 3 Things You Need to Know](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Novavax Stock Upgraded: 3 Things You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
![Why Geron Corporation Stock Is Jumping Today](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Why Geron Corporation Stock Is Jumping Today
Shares of the clinical-stage biotech Geron Corporation (NASDAQ: GERN) rose by as much as 13.5% in early morning trading today, thanks to a Fast Track designation from the U.S. Food and Drug....
![Pfizer Inc. Q3 Earnings: The Most Important Things to Know](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Pfizer Inc. Q3 Earnings: The Most Important Things to Know
Pfizer's (NYSE: PFE) overall story so far in 2017 has been a mediocre one. The big pharma company's stock is up year to date, but barely half as much as the S&P 500 index. Although Pfizer....
![Exact Sciences' Earnings Hammer Short-Sellers (Again)](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Exact Sciences' Earnings Hammer Short-Sellers (Again)
Americans have historically done poorly when it comes to sticking to recommended guidelines for colon cancer screening, but a new test launched by Exact Sciences (NASDAQ: EXAS) may be changing....
![If Celgene Buys This Biotech, Investors Should Win Big-Time](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
If Celgene Buys This Biotech, Investors Should Win Big-Time
Celgene (NASDAQ: CELG) has fallen on hard times of late -- or its stock has, at least. At the beginning of October, the biotech's share price was up 25% year to date. By the end of the month,....
![Why Adamas Pharmaceuticals Inc. Jumped Higher Today](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Why Adamas Pharmaceuticals Inc. Jumped Higher Today
Adamas Pharmaceuticals (NASDAQ: ADMS) closed up 21% on Monday, after Point72 Asset Management disclosed in an SEC document on Friday after the bell that it boosted its stake in the drugmaker.The....
![Better Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Better Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson
With multiple catalysts likely to fuel its growth, the healthcare sector is fertile ground from which investors can reap sizable profits -- if you know where to look.To help you in this regard,....
![Global Blood Therapeutics Inc. Jumped as Much as 14% on This News](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Global Blood Therapeutics Inc. Jumped as Much as 14% on This News
Shares of San Francisco-based Global Blood Therapeutics (NASDAQ: GBT), a small-cap developer of experimental therapies focused on treating blood-based disorders, rocketed higher by as much as 14%....
![Celgene Corporation Has "Optionality and Opportunity"](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Celgene Corporation Has "Optionality and Opportunity"
Celgene (NASDAQ: CELG) got crushed after announcing third-quarter earnings, saying revenue would come in at the bottom of previous guidance, and lowering its 2020 guidance. All things considered,....
![Why Advanced Accelerator Applications SA Acquired a Higher Price Today](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Why Advanced Accelerator Applications SA Acquired a Higher Price Today
Advanced Accelerator Applications (NASDAQ: AAAP) is up 10.5% at 11:42 a.m. EDT after announcing that it was being acquired by Novartis (NYSE: NVS) for approximately $3.9 billion.Advanced....
![Why TransEnterix Stock Is Rebounding Today](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Why TransEnterix Stock Is Rebounding Today
TransEnterix (NYSEMKT: TRX), a small-cap robotic-surgery company, is on the rebound today with its shares up by 21.41% on heavy volume, as of 11:05 a.m. EDT.Prior to today's double-digit move,....
![3 High-Yield International Stocks](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
3 High-Yield International Stocks
Because of the generally more favorable corporate tax rates abroad, international stocks can, on occasion, offer enormous yields that are sustainable in the long term. The international investing....
![2 Top Pharma Stocks on Sale This Week](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
2 Top Pharma Stocks on Sale This Week
Like most investors, I love a good bargain. So when the top pharma stocks Celgene Corporation (NASDAQ: CELG) and GlaxoSmithKline plc (NYSE: GSK) both crashed last week, it definitely caught my....
![3 Reasons I've Been Aggressively Buying Intercept Pharmaceuticals](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
3 Reasons I've Been Aggressively Buying Intercept Pharmaceuticals
I admit it: I love trying to catch a falling knife. Sometimes you get sliced in the process, while at other times you leave vindicated by having gone against the grain. My belief is that small-cap....
![The 3 Best Diabetes Stocks to Buy in 2018](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
The 3 Best Diabetes Stocks to Buy in 2018
Diabetes is a chronic condition that occurs when the body loses its ability to properly metabolize sugar. Without treatment, people with diabetes end up with too much sugar flowing through their....
![How to Invest in Healthcare](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
How to Invest in Healthcare
Ten thousand Americans will turn 65 years old every day from now through 2029. As those Americans age, they will transform our country's healthcare system -- to the tune of a 5.8% annual increase....
![3 Biotech Stocks That Turned $1,000 Into More Than $5,000 This Year](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
3 Biotech Stocks That Turned $1,000 Into More Than $5,000 This Year
It's been a banner year for anyone who started 2017 holding shares of AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), XOMA Corporation (NASDAQ: XOMA), or Dynavax Technologies Corporation (NASDAQ:....
![5 Things You Need to Know From Gilead Sciences' Q3 Update](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
5 Things You Need to Know From Gilead Sciences' Q3 Update
You could probably fit the number of people surprised by Gilead Sciences' (NASDAQ: GILD) third-quarter results inside a phone booth -- if you could even find one. Hepatitis C virus (HCV) drug....
![A Me-Too Push By Biopharma Is Crowding the Psoriasis Market](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
A Me-Too Push By Biopharma Is Crowding the Psoriasis Market
A wave of R&D is leading to next-generation psoriasis drugs that work better than ever. That's great news for patients desperate for new treatment options, but it's bad news for biopharma....